Editorial Board
Dr. Scicchitano Pietro completed his degree in Medicine and Surgery with maximum votes, discussing a thesis entitled “Evaluation of cardiovascular risk in patients suffering from Polycystic Ovary Syndrome”. He completed his Ph.D. in Biomolecular, Pharmacological and Medical Science from the Department of Oncology, University of Bari, Italy. He is a member of the directive nucleo of Hypertension, Prevention and Rehabilitation Group of Italian Society of Cardiology. Dr. Pietro is the author of 130 articles in International Scientific Journals, with 250 abstracts published in International Journals and 4 chapters of scientific books.
M. Michalak is a Distinguished University Professor of Biochemistry, Faculty of Medicine & Dentistry, University of Alberta, Fellow of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. He holds PhD degree in Biochemistry from the Nencki Institute for Experimental Biology, Warsaw, Poland. He served as Chair of the Department of Biochemistry and as a Vice-Dean (Research), Faculty of Medicine & Dentistry at the University of Alberta. He has been recognized by numerous prestigious distinctions including the University Cup which is among the highest honours that the University of Alberta confers on its faculty members. His research interests are in the areas of molecular chaperones, protein folding and regulation of calcium homeostasis. He has published more than 260 scientific publications.
Dr. Mukherjee, M.D is the Chairman of the Department of Internal Medicine and the Program
Director for the Cardiovascular Medicine Fellowship program at the Texas Tech University Health
Sciences Center at El Paso. Dr Mukherjee has been an invited lecturer at several major national
and international meetings, has authored over 450 publications, edited eighteen textbooks on
cardiovascular diseases and written more than 100 textbook chapters. He presently serves on
several journal editorial boards, is the Editor-in-Chief of the
MD and Cardiology Board, Sapienza, University of Rome, Post Doc Certificate of Hemodynamics, University of Montreal, CND and Post Doc Certificate of Experimental Surgery, University of Marseilles, F; PhD and HDR, University of Caen, F has French National Qualification as Full Professor of Physiology and Italian National Qualification as Associate Professor of Cardiology. Member of Cardiological Societies (FESC, FACC). Referee for more than 50 Journals has research interests in Clinical Cardiology, Imaging Technologies, CV Epidemiology and Biostatistics and in vitro Electrophysiology and Pharmacology.
Dr. Shen is the Professor in the Departments of Internal Medicine in the University of Manitoba. He graduated and received Master and Doctorial degrees from Shanghai Jiaotong University School of Medicine, and worked as physician in Shanghai Institute of Hypertension and Department of Cardiology in Shanghai Ruijin Hospital. He received postdoctoral training in University of Iowa, Cleveland Clinical Foundation, and University of Alberta. He has joined the Section of Endocrinology, Department of Internal Medicine, Faculty of Medicine in University of Manitoba since 1991 and promoted as Professor in 2006. His research program aims to mechanism and management of for diabetic cardiovascular complications and gestational diabetes. He published >100 peer reviewed papers and received a number of national and international awards and recognitions including Editor-in-Chief of Cardiovascular and Hematological Disorders-Drug Target, Advisory Professor in Shanghai Jiaotong University School of Medicine, and Councilor of Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology.
Dr. Wang, MD, FAHA, is Professor of Medicine, Neuroscience Program, and Cell and Molecular Biology Program at Michigan State University. Dr. Wang is an Established Investigator of American Heart Association, a Fellow of the American Heart Association Council for High Blood Pressure Research, and a Fellow of Cardiovascular Section of the American Physiological Society. Dr. Wang's research interests lie in molecular intervention, neuroscience, cardiovascular medicine, drug discovery, and nanomedicine. Her laboratory discovered that the transient receptor potential (TRP) channels play a central role in the “salt pathway”. These molecules signal a particularly exciting breakthrough, as they are capable of protecting tissues/organs from inflammation and injury. Specifically, data from her laboratory indicate that TRP channels, activated by novel lipid metabolites, may serve as distinct molecular sensors detecting micro-environmental changes occurred under pathophysiologic conditions including hypertension, myocardial infarction, and metabolic disorders including diabetes and obesity.
Massimo Mapelli is a cardiologist of the Heart Failure Unit of the Monzino Cardiology Center, IRCCS (Milan). He holds a PhD in Translational Medicine, University of Milan (2022). He graduated with honors in Medicine (Brescia, 2009) and in Cardiology (Milan, 2016) with a thesis on a prognostic score developed on more than 6000 heart failure patients. He has been involved in clinical and research activity in the field of cardiology. In 2019, he completed a European master (PCHF, University of Zurich - European Society of Cardiology) and he has recently been admitted to a master's program at Oxford. He presented several abstracts in national and international congresses and he published more than 100 articles in the indexed scientific journals.
Dr. Acampa obtained a post-graduate degree in Internal Medicine (2002) and a doctorate (Ph.D.) in Clinical Pharmacology (2007) at the University of Siena, Italy. Currently, Dr. Acampa is a medical doctor at the Stroke Unit - Department of Medicine, Surgery and Neurosciences of the University of Siena. Teacher in various degree courses of the Faculty of Medicine, University of Siena. He is author of roughly 100 scientific publications. His main research interests include: immunologic and inflammatory mechanisms of cardiac arrhythmias, cardiac autonomic nervous system alterations, and cardiovascular involvement in stroke and in systemic autoimmune diseases.
Dr. Suna Aydin received her Doctor of Medicine degree (MD) from School of Medicine, University of Firat, Elazig in 1998. In 2011 at the Dicle Medical School she received her Specialization degree in Cardiovascular Surgery, and in 2015 she received her PhD diploma Anatomical Science from Firat University Institute of Health Sciences. She currently works as a Surgeon at Department of Cardiovascular Surgery of Elazig Education & training Hospital of Elazig Campus of Health Sciences University, she is the author of numerous scientific articles within the field of cardiac surgery and anatomical sciences. She has served as an editorial board member of several international journals and she is reviewer for several international journals.
Dr. Younis Baqi is an Assistant Professor of Bioorganic and Pharmaceutical Chemistry and coordinator of the Applied Chemistry at Sultan Qaboos University. His early training was in natural products chemistry at the University of Jordan (MSc) and pharmaceutical chemistry at University of Bonn (PhD). Dr. Baqi was visiting scholar at the laboratory of Prof. E.J. Corey, Harvard University; MA, USA. After a research stay at the laboratory of Prof. E.J. Corey, Harvard University; MA, USA, he appointed as group leader within ERA-NET fellowship.
Dr. Conti received degree in Biology in 2001, PhD in Pharmacology and Clinical and Experimental Medicine in 2010 and Post degree specialization in Pharmacology in 2011. Her main research fields are Genetics and Pharmacogenetics, Toxicology and Appropriateness of pharmacological treatment, Oxidative Stress, Aging, Physical Exercise in Health and Disease, Cardiovascular and Respiratory diseases. Dr. Conti is a permanent scientific contributor of Pharmacogenetic Newsletter of Pharmacology Italian Society (SIF) of which she is a member. She has published papers in peer-reviewed journal and is referee of international peer review journal (European Journal of Pharmacology, World Journal of Medicine and Medical Science Research, Journal of Clinical Endocrinology & Metabolism).
Dr. Carella (MD) after graduating in Medicine, obtained specialization in Internal Medicine, attended postgraduate courses on Diabetes and Obesity and obtained university Master in Healthcare Management. Currently Dr. Carella operates at the Internal Medicine Department of "T. Masselli - Mascia" Hospital in San Severo (Foggia), Italy. He teaches at Medical Faculty of Foggia University, degree course in Health Professions. Dr. Carella is Editorial Board member and Reviewer of several scientific journals and author of several scientific publications (h-index 5, according to Google Scholar citation search; ORCID iD: 0000-0003-4825-9620).
Dr. Cantinotti obtained medical degree in 2004, and specialization in Cardiology in 2008 at Pisa University. From 2009 up to now, he has been working as a pediatric Cardiologist in the Pediatric cardiology and G.U.C.H. Unit of FTGM, Massa, a tertiary Italian Center. He is expert in echocardiography and has a specific skill for reasearch. He has published more than 70 scientific publications and he is author of an App “Baby Norm: Pediatric Normal Values and Drug Doses Calculator”. Dr Cantinotti's main field of research are: 1) pediatric (and adult) echocardiographic normal values,2) lung ultrasound applications in pediatric cardiology and cardiac surgery, 3) biomarkers in pediatric cardiology and cardiac surgery.
Dr. Chen is an Associate Professor of Department of Pathology and Laboratory Medicine at UT Southwestern Medical Center. He received his Medical Degree from Peking University Health Science Center in 1992 and PhD in pharmacology from Kyoto University of Japan in 2001. He had his Pathology Residency training at UC San Diego in 2005 and at Loma Linda University Medical Center from 2006 to 2009, followed by a hemapathology fellowship at City of Hope supervised by Dr. Lawrence Weiss in 2010. He was appointed as an Assistant Professor at the UC Davis in 2010, and promoted to Associate Professor in 2014. He moved to UTSW medical center in 2016. His research focuses on viral infection in the pathogenesis of lymphoma and leukemia, tumor immunology, cancer stem cells, GVHD and sickle cell disease. He has published over 100 peer reviewed papers, abstract and book chapters.
Dr. Roberto Castelli MD is an assistant professor of Hematology at the University of Milan. He completed his post-graduated specialty in Hematology and Internal Medicine. His scientific interest is mainly in the field of myeloid diseases such as Myelodisplastic and Myeloprolipherative neoplasms. One point of interest is cancer related thrombosis and bleeding. He has published around 60 original papers, some of excellence as Autoimmunity review, Journal of Allergy and Clinical Immunology, Hematological, British journal of Hematology, Journal of Clinical Oncology and Blood, American journal of Hematology. He is also teaching in Hematology and Internal Medicine in various degree courses. He is also involved in Clinical activity in Hematology and Coagulopathies division at University Hospital of Milan.
She was graduated in Medicine and Surgery at the University of Bari with maximum votes, praise and academic acclaim. She took the specialization in cardiology at the University of Bari in with maximum votes. She is attending the doctorates at University of Bari and works as Cardiologist at Hospital “Dimiccoli” in Barletta. Expert in echo color Doppler ultrasound, transthoracic, transesophageal echocardiography (mono-bi dimensional and 3D) and intracardiac one. Active in clinical research in the field of cardiac and vascular ultrasound and endothelial function using the technique FMD (flow mediated dilation). Author of several international scientific manuscripts. Reviewer for several international journals.
Dr. Yuqi Cui, M.D., Ph.D., is currently one of the Young Faculty Members at the American Heart Association. He started his research in 2009 in the Davis Heart and Lung Research Institute at The Ohio State University, Columbus, Ohio, USA. Since 2014, Dr. Cui’s main research focus is towards the effects of air pollution on BMSCs and EPCs. At present, he is an Assistant Professor in the Department of Medicine at University of Missouri Columbia, Missouri, USA. Dr. Cui, as an author/co-author, has published more than 20 articles in various journals.
Dr. Amalia Forte obtained a degree in Life Sciences from the University “Federico II”, and a Doctorate from the Università della Campania “L. Vanvitelli”, both in Naples, Italy. Dr. Forte is currently a Research Scientist at the Università della Campania “L. Vanvitelli”, and her research interests are focused mainly on the pathogenetic bases of aortopathy associated with bicuspid aortic valve, with a special focus on Tgf-b1 and related biomolecular pathways. Dr. Forte is main author of several papers and is member of the editorial board of numerous indexed journals.
Dr. Franco obtained his PhD degree in Biological Sciences at the University of Malaga (Spain). Subsequently Dr. Franco was a post-doctoral fellow at the Department of Anatomy and Embryology of the University of Amsterdam (NL), getting extensive experience in molecular embryology. Currently he is Associate Professor in Cell Biology at the Experimental Biology Department of the University of Jaén (Spain) and his scientific interests are focused on transcriptional and post-transcriptional regulation of cardiac development and disease. He has published more than 90 scientific publications, three international patents and is associated editor and reviewers of distinct top ten international journals in the cardiovascular field.
Tahereh Farkhondeh received her PhD in Toxicology from the Tehran University (Tehran, Iran), and is currently serving as a faculty member at the Cardiovascular Diseases Research Center Birjand University of Medical Sciences. She has published several articles in ISI Web of Science Database that are mainly in the field of toxic agents and natural antioxidants and their effects on health and disease and their molecular actions, especially on the underlying mechanism pathways in cardiovascular and neurodegenerative diseases.
Dr. Fanos, MD, works as a Prof. & Director at Pediatrics University of Cagliari, he is also the Director of NICU and Neonatal Section AOU of Cagliari, Italy. He is the President of the National Pediatric Commissions on Risk Management of the Italian Society of Pediatrics. He has more than 500 publications (of which 345 on Pub Med, 10 in other journals with IF in National and International Journals (including Lancet). He has received first prize in national Italian Congress of Laboratory Medicine and in foreign meetings (1st award in Athens, Resuscitation Meeting). He also served as an editorial board member for number of peer review journals.
Guido Gelpi is involved as first operator in endovascular procedures for thoracic and abdominal aorta (TEVAR and EVAR) and in structural heart disease therapies (TAVI and MitraClip). Scientific coordinator of ForcardioLab for the development of new cardiovascular therapies. Author of more than 40 papers PubMed indexed in the cardiovascular therapy field and more tha 180 abstracts. Member of the Euorpean Association for Cardio-thoracic Surgery and the Italian Society of Cardiothoracic Surgery
Dr. Hou is Distinguished Corp. fellow of BSC, & Associate Professor of Clinical Research at Mercer Univ., Visiting Professor at Harbin Med. Univ. and Tongji Univ. He has more than 200 scientific publications, and is a named inventor of 7 issued U.S patents. Dr. Hou has more than 60 invited lectures. He also served as an editorial board member for number of peer review journals; abstract reviewer for several Annual Scientific CV Conferences; and a grant reviewer for American Heart Association Vascular Endo Bio Clinical grant.
Dr. Hammami, is Professor of Internal Medicine –Geriatrician University of Monastir, Tunisia. She is President of the Tunisian Geriatric Association. Her research activities focused on Metabolic disorder (Diabetes, Hypertension), Risk factors (Atherosclerosis),, Use of drugs in older people, Undernutrition, Frailty and age related diseases, Depression, Alzheimer’s disease. She has published 80 research publications. She is editorial board member of other International refereed journals and also associated with scientic socities.
She is Professor in Pediatrics MD Anderson Cancer Center, received her A.B. degree from Washington University in St. Louis, and her MD degree from Duke University. She completed her pediatric residency at the Children’s Hospital National Medical Center in Washington, DC, followed by a fellowship at the National Cancer Institute in Bethesda, MD. She was a Senior Investigator at the NCI-Frederic Cancer Research Facility then recruited to MD Anderson Cancer Center & Head of Pediatrics and Children’s Cancer Hospital at MD Anderson from 2001-2015. She has an international reputation in sarcoma research and the development of novel therapeutic approaches. She received the Distinguished Medical Alumnus Award from Duke University, the Faculty Achievement Award for Clinical Research and Distinguished Alumni Award from Washington University.
Dr. Kones obtained a Medical Doctorate from the New York University School of Medicine, and during that time began his research career. He has held academic appointments at New York Medical College and Tulane University, and has been involved in medical education in numerous venues. His investigative interests have been preservation of ischemic myocardium, molecular mechanisms in cardiometabolic disorders, and reducing cardiovascular risk. A Fellow and member of many cardiology societies, he is an advocate for many public health initiatives, including for the American Heart Association. With a broad-based scholarly background, Dr. Kones brings extensive editorial expertise to this Journal.
Dr. Karimi is an academic member in the Razi University from 2008. He received his Doctor of
Veterinary Medicine (DVM; 1998-2004) from Shahr-e-Kord University, Iran and Doctor of Veterinary
Sciences (DVSc; 2004-2008) in physiology from Urmia University, Iran. I.K. has an
interdisciplinary view, however he is concentrated on ethnopharmacology, translational research,
nanotoxicology, computational biology and biomathematics. He is research founder of
Dr. Li is a Professor and the Scientific Director of the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China. Dr. Li graduated from Shanghai Medical University, obtained her Ph.D. from Karolinska Institute in Sweden, and received her postdoctoral training at the Karolinska Institute and the Vesalius Research Center, Leuven University, Belgium. During 2005-2012, Dr. Li served as a Principal Investigator at the National Institutes of Health, National Eye Institute in USA. Dr. Li has published more than 70 scientific publications and is a referee for more than 20 international journals. She is an inventor of many international patents. Dr. Li has research interests in vascular biology, cardiovascular diseases, translational research and drug discovery.
Dr. Lymperopoulos obtained his Ph.D. in Pharmacology from the University of Patras, Patras, Greece. He then moved on to join the lab of Dr. Walter Koch, a former postdoctoral fellow of Nobel laureate Robert Lefkowitz`s lab at Duke University. Dr. Lymperopoulos is a Fellow of the American Heart Association (FAHA) a Fellow of the European Society of Cardiology (FESC). He has received numerous funding awards, including a 5-year Scientist Development Grant from AHA. He has also been a finalist for the AHA-sponsored Melvin L. Marcus Young Investigator Award in Basic Cardiovascular Sciences, and for the Cardiovascular Research Award of the Council on Basic Cardiovascular Sciences of the European Society of Cardiology (ESC).
He is a Consultant in the Dept. of Vascular Surgery, Attikon University Hospital, Athens, Greece. He has more than 105 international publications. He participated in unfunded and funded clinical studies (GALA Trial, ACST II) and protocols. He is member of the Collaborative Research (CORE) Group, Sydney, Australia (International Advisory Committee) and also a member of the European Society for Vascular Surgery. He currently serves as secretary of Hellenic Society for Vascular and Endovascular Surgery and secretary of Hellenic Society of Phlebology. He has received several honors, praises, and awards in Greece and Europe and an educational grant from the European Society of Vascular Surgery. He is Editorial Board of International peer review journals and reviewer.
Dr. Alessandro Morotti obtained his MD degree at the University of Piemonte Orientale - Italy, the Internal Medicine residency at the University of Turin - Italy, and the PhD in Medicine and Experimental therapy at the University of Turin, Italy. His research activities focused on the mechanisms of tumor suppressors functional inactivation in tumorigenesis and in physiological processes. He is also interested in the evaluation of determinants of platelets aggregation. Currently he is Assistant Professor at the University of Turin and works as a clinician at the San Luigi Hospital, Division of Internal Medicine/Hematology Division.
Dr. Prandota received his Doctor of Medical Sciences degree (1970) and PhD degree (1980) from Wroclaw Medical University, Poland. He worked as Assistant/Adjunct in Dpt of Pharmacology (1966-1975), Dpt of Pediatric Nephrology (1975-1977), the Associate Professor, Full Professor and Chief in Dpt of Pediatrics, J. Korczak Memorial Children’s Hospital in Wroclaw (1978-2002), and then in the Faculty of Dentistry, and as the Chair and Head of the Dpt of Social Pediatrics, Faculty of Health Sciences, Wroclaw Medical University (2002-2011). He published 65 peer-reviewed papers as the only or first author. His research focused on Latent chronic T. gondii infection and its participation in development of molecular pathomechanisms of headaches, several neurodegenerative, and autoimmune diseases.
Dr. Perrotta obtained a degree in Biological Sciences and a doctorate (Ph.D.) in Animal Biology from the University of Calabria. She also holds a Master's degree in “Microscopy applied to biology, medicine and environmental sciences”. Currently Dr. Perrotta is chief technician of Transmission Electron Microscopy Unit at the Centre for Microscopy & Microanalysis (CM2), University of Calabria. She has published more than 60 scientific papers and is actively involved in research as well as in a number of international projects in the atherosclerosis field.
Liren Qian has been in the field of medicine for more than 10 years, who devoted himself to hematology. He has published more than 20 papers and participated in one international book in the past 5 years. Citations of those papers have reached more than 400 times. He led three clinical trials in China. He served as Reviews Editor in Frontiers in Pharmacy and Frontiers in Oncology. He also served as a lead guest editor in one special issue in Oxidative Medicine and Cellular Longevity and a guest editor in one special issue in Stem Cells International. He is also in charge of 5 national grants. He is professional in the diagnosis and treatment of leukemia, lymphoma and multiple myeloma, malignant blood system diseases and various kinds of anemia. He is also professional in the treatment of complex complications after hematopoietic stem cell transplantation.
Dr. Daniel González obtained PhD in Biological Sciences from Pontificia Universidad Católica de Chile, Santiago, Chile in 2005. He is presently serving as an Associate Professor at the Department of Basic Biomedical Sciences, Faculty of Health Sciences in University of Talca. He has also been recognized with awards such as Travel Award from The Physiological Society in 2004 and Merck-Sharp & Dohme Award in 2005. He is also a member of American Heart Association, International Society for Heart Research, British Pharmacological Society and Biophysical Society.
Dr. Pietro Scicchitano obtained his Degree in Medicine and Surgery in 2008 discussing a thesis entitled, “Evaluation of cardiovascular risk in patients suffering from Polycystic Ovary Syndrome”. Additionally, he also has a Degree of Instructor in Basic Life Support and Defibrillation (obtained in 2007). He is currently affiliated with University of Bari, Bari, Italy. His skills and expertise mainly lie in the subject areas of Hypertension, Heart Failure, Inflammation, Insulin Resistance, Atherosclerosis, Diabetes, Echocardiography, Myocardial Infarction, Blood Pressure, Pharmacology, Cardiology, Biomarkers, etc. Dr. Scicchitano is an author/co-author of over 110 full articles in international scientific journals, has 170 abstracts published in international journals, and has also published 4 chapters in scientific books.
Dr. Santoro is a cardiologist, phD student at the university of Foggia Italy and consultant in Electrophysiology at Bonomo Hospital , Andria, Italy. In 2013, during the cardiology residency he attended for six months Texas Arrhythmia Institute, Austin, Texas, USA under the supervision of Dr. Andrea Natale. Between 2015 and 2018 he attended the electrophysiology laboratory at the Department of Cardiology, Asklepios Klinik St. Georg, Hamburg. Research topic: Cardiomyopathies (Takotsubo syndrome) and catheter ablation of Atrial Fibrillation and Ventricular Tachycardia (Papillary muscles Vt/VF). He authored 115 publications in indexed journals, about 135 abstracts and 5 electrophysiology book chapters.
Dr Starakis M.D, pH.d., obtained a doctorate in Medicine (Ph.D) from the University Of Patras, Greece. He was trained in the prevention and control of nosocomial infections at Clatterbridge Hospital, Wirral, NHS Trust, England.
His current appointment is Professor of Medicine in Patras University, Rion, Patras, Greece and he is the head of the 1st Division of Internal Medicine Department in Patras University Hospital. He has published more than 80 scientific publications and has a perennial educational work , both at undergraduate and postgraduate level. He has also participated in seminars to physicians and postgraduate programs in a number of regional hospitals. He also is a speaker at several local and nation-wide Medical Conferences and scientific events.
Dr. Strauer, is Professor at the Department of Cardiology, University of Duesseldorf, Guest Professor, Cardiac Surgery, Medical Faculty, University of Rostock, Germany. His research focused on Myocardial contractility, energetics and coronary flow reserve, Hypertension and the Heart and Stem cell research in Cardiology. He has more than 600 publications in internationally peer-reviewed journals.
Dr. Qi’s major research interests are the clinical researches in the etiology, diagnosis and management of liver cirrhosis, portal hypertension (especially portal vein thrombosis and Budd-Chiari syndrome), and hepatocellular carcinoma. His major work was published in the Nature Reviews Gastroenterology and Hepatology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Thrombosis and Haemostasis, American Journal of Medicine, etc. He served as an Associate Editor of Annals of Hepatology and a lead guest editor in two special issues in two SCI journals, Gastroenterology Research and Practice and BioMed Research International. He also served as a peer-reviewer in more than 30 SCI journals.
Dr. Pollen Yeung obtained his Ph.D. in Pharmaceutical Chemistry and Pharmacokinetics from the University of Saskatchewan, Saskatoon, SK, Canada. He is currently Professor in Pharmacy and Medicine at Dalhousie University, Halifax, NS, Canada. He has published more than 80 scientific manuscripts and 150 abstracts. Dr. Yeung is currently Editor-in Chief for Cardiovascular Pharmacology Open Access, and a member on the Editorial Board for Natural Product Chemistry and Research (both published by Omnics Publishing Group), Metabolites (published by MPGI AG), Current Drug Safety (published by Bentham Science Publishers), and Medical Sciences Monitor (published by International Scientific Information, Inc).
Dr. Chengfeng Bi, M.D., Ph.D. is a medical scientist at the University of Nebraska Medical Center, United States. His research field is hematological malignancies, especially in Non-Hodgkin’s Lymphoma (NHL). He has extensive experience in multi-disciplinary research including cancer biology and translational medicine. Dr. Chengfeng Bi’s current research focuses on identifying novel therapeutic strategies for hematological malignancies based on the understanding of oncogenic mechanisms.
Nader Cohan is an assistant professor of hematology and blood banking. He is a membership of Shiraz University of Medical Sciences, Shiraz, Iran. His experience in hematological disorders with publishing around 40 papers in this field.
Mei I Lai graduated with BSc. Biomedical Science (First Class honours) from Universiti Putra Malaysia was awarded a PhD in Gene and Cell-based Therapy from King’s College London. She is currently an Associate Professor in the Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. She is a prolific researcher having published in numerous international journals and co-authored several books. Her research focus was built on the foundation of exploring hereditary red blood cell disorders in particularly thalassaemia. The other thrust of her research work is on creating low cost innovative tools for screening purposes.
My research activity has been mainly focused on the investigation of lipoprotein pathophysiology through (i) generation of mice that express human proteins involved in lipoprotein metabolism, (ii) definition of genotype-phenotype relationships, (iii) characterization of specific pathways of lipid/lipoprotein metabolism. Moreover, using different animal models, I have investigated the effects of novel dietary or pharmacologic treatments on atherosclerosis progression/regression in vivo by invasive (IntraVascularUltraSound-IVUS) and non-invasive techniques (magnetic resonance imaging-MRI), and ex-vivo by histology. Finally, my research activity moved on the gut-microbiota axis and on the relationship between HDL and rare diseases. Actually, my experimental goal is that of finding functional foods able to reduce the risk of cardiovascular disease or the incidence of rare pathologies.
